Global Glycobiology Market, By Product Type (Instruments, Enzymes (Galactosidases (Fucosidases, Chitinases, Acetylgalactosaminidase, Heparinase, PNGase F, and Others), GlcNAc Transferases (Acetylglucosaminyltransferase, Exostosin, and Others), Fucosyltransferases, GalNAc Transferases, Galactosyl Transferases, Glucuronosyltransferases, Glucosyltransferases, Pentosyltransferases, Carbohydrate Kinases, Neuraminidases, Sialyltransferases, and Others), Consumables, Reagents & Kits), By Application (Drug Discovery and Development, Diagnostic Applications (Oncology, Immunology, and Others), Industrial Application, Therapeutic Application (Oncology, Immunology, and Others), and Others), By End User, (Pharmaceutical Companies, Research Laboratories, Hospitals, Diagnostic Centers, Contract Research Organizations, Biotechnology Companies, Academic Institutes, and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ $ 1,165.3 Mn in 2020 and is expected to exhibit a CAGR of 12.8% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

The increasing number of product launches such as mass spectrometry devices, high profile liquid chromatography (HPLC) devices, and others is expected to drive the global glycobiology market growth. For instance, in May 2019, Shimadzu Corporation announced the launch of Novel Shimadzu MALDImini-1 Digital Ion Trap Mass Spectrometer, which provides fast, high-sensitive measurements through an ultra-compact design for clinical and laboratory research.

Global Glycobiology Market– Impact of Coronavirus (COVID-19) Pandemic

Supply chain and manufacturing activities in India, Italy, Spain, the U.K., and the U.S. have been disrupted due to lockdowns implemented by various governments in the past few months, while countries such as Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of drug products. The coronavirus or COVID-19 outbreak that started from Wuhan, China, has spread across continents, affecting various industries globally. Supply of key materials has been severely disrupted due to forced quarantine and lack of labor and raw materials.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/3639

As the supply link between regional warehouses is not smooth, the transportation of raw materials between various regions cannot be carried out successfully. This shortage of raw materials and components have affected the supply chain of the global glycobiology market. The COVID-19 pandemic has impacted the global economy and in turn, the glycobiology market.

Browse 43 Market Data Tables and 14 Figures spread through 195 Pages and in-depth TOC on “Global Glycobiology Market”- Forecast to 2027, Global Glycobiology Market, By Product Type (Instruments, Enzymes (Galactosidases (Fucosidases, Chitinases, Acetylgalactosaminidase, Heparinase, PNGase F, and Others), GlcNAc Transferases (Acetylglucosaminyltransferase, Exostosin, and Others), Fucosyltransferases, GalNAc Transferases, Galactosyl Transferases, Glucuronosyltransferases, Glucosyltransferases, Pentosyltransferases, Carbohydrate Kinases, Neuraminidases, Sialyltransferases, and Others), Consumables, Reagents & Kits), By Application (Drug Discovery and Development, Diagnostic Applications (Oncology, Immunology, and Others), Industrial Application, Therapeutic Application (Oncology, Immunology, and Others), and Others), By End User, (Pharmaceutical Companies, Research Laboratories, Hospitals, Diagnostic Centers, Contract Research Organizations, Biotechnology Companies, Academic Institutes, and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).

Moreover, rise in research and development related to oligosaccharides is also expected to aid in growth of the global glycobiology market over the forecast period. For instance, in February 2020, researchers from University of Kentucky, U.S. reported the use of a high-throughput assay to determine the effect of various post-translational modifications of the Chondroitin sulfate proteoglycansaggrecan upon neurite outgrowth from NS-1 cells.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/glycobiology-market-3639

Key Takeaways of the Global Glycobiology Market:

The global glycobiology market is expected to exhibit a CAGR of 12.8% during the forecast period owing to the increasing focus on manufacturing anti-cancer drugs, this is expected to boost growth of the market. For instance, in January 2020, researchers from Universidade do Porto, Portugal, assessed the role of O-glycosylation using glycoengineered gastric cancer models in the detection of CD44v9 – a major protein splice variant isoforms expressed in human gastrointestinal cancer cells—using monoclonal antibodies.

Among Applications, Drug discovery and development segment is accounted for the largest market share in global glycobiology market in 2020. Moreover, investments on drug discovery and development by the key players operating in the market is expected to drive the segment growth over the forecast period. For instance, Merck invested around US$ 9,872 million and US$ 9,752 million on research and development in 2019 and 2018, respectively.

Among the regions, Asia Pacific is estimated to exhibit higher CAGR in the global glycobiology market over the forecast period. For instance, in June 2019, a group of Japanese scientists from different universities and research institutes discovered a novel SGL enzyme ((TfSGLr) from a soil fungus, Talaromyces funiculosus. This enzyme TfSGL protein (TfSGLr) was found to break down both linear and cyclic β-1,2-glucans for carbohydrate metabolism.

Major players operating in the global glycobiology market are Merck & Co., Inc., Bio-Techne Corporation, Bruker Corporation, Thermo Fisher Scientific Inc., Shimadzu Corporation, Plexera LLC, New England Biolabs, and Agilent Technologies, Inc.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/3639

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737